Genomics for Obstetrics & Gynecology

68
Human Genome Project Potential Applications

description

Genomics could be difficult to understand for gynecologists. In this talk we will try to make it simple .

Transcript of Genomics for Obstetrics & Gynecology

Page 1: Genomics for Obstetrics & Gynecology

Human Genome Project

Potential Applications

Page 2: Genomics for Obstetrics & Gynecology

In March, 2002

Doctors successfully screened embryos for gene mutation linked to early onset Alzheimer's

JAMA, March, 2002

Page 3: Genomics for Obstetrics & Gynecology

A Great Success

Page 4: Genomics for Obstetrics & Gynecology

BasicsInside the nucleus of every cell in the body, a complex set of genetic instructions, known as the human genome, contained on pairs of chromosomes.

Page 5: Genomics for Obstetrics & Gynecology
Page 6: Genomics for Obstetrics & Gynecology

Chromosomes are long chains of DNA-deoxyribonucleic acid.

Page 7: Genomics for Obstetrics & Gynecology
Page 8: Genomics for Obstetrics & Gynecology
Page 9: Genomics for Obstetrics & Gynecology

Base codeHereditary instructions are written in a four-letter code, with each letter corresponding to one of the chemical constituents of DNA: A, G, C, T.

Page 10: Genomics for Obstetrics & Gynecology
Page 11: Genomics for Obstetrics & Gynecology

GeneA gene is a chromosomal region capable of making a functional transcript.

Page 12: Genomics for Obstetrics & Gynecology
Page 13: Genomics for Obstetrics & Gynecology
Page 14: Genomics for Obstetrics & Gynecology

ThusA genome is all the DNA in the cell, including its genes. Errors in genes--the smallest units of heredity-- may cause or contribute to disease

Page 15: Genomics for Obstetrics & Gynecology
Page 16: Genomics for Obstetrics & Gynecology
Page 17: Genomics for Obstetrics & Gynecology

HoweverMany genes are co-expressed with their own antagonist

Page 18: Genomics for Obstetrics & Gynecology

The resultAll diseases have a genetic component, whether inherited or resulting from the body's response to environmental stresses like viruses or toxins

Page 19: Genomics for Obstetrics & Gynecology

GenomicsStructural genomics: to identify all the approximate 30,000 genes in human DNA Functional genomics: to understand gene-gene interaction

Page 20: Genomics for Obstetrics & Gynecology

Objectivesdetermine the sequences of the 3 billion chemical base pairs that make up human DNA, store this information in databases explore potential application in

practical life

Page 21: Genomics for Obstetrics & Gynecology
Page 22: Genomics for Obstetrics & Gynecology

The concept

How & Which genes play a role in disease

causation

Page 23: Genomics for Obstetrics & Gynecology

ToolsAn increasing number of gene tests are becoming available commerciallyMicro-array composed of five separate array each of which has about 10,000 target

Page 24: Genomics for Obstetrics & Gynecology
Page 25: Genomics for Obstetrics & Gynecology
Page 26: Genomics for Obstetrics & Gynecology

Genomic MedicineDiagnosisMonitoring of progresstreatment of disease

Prevention

Page 27: Genomics for Obstetrics & Gynecology

ExampleUsing tools emerging from the Human Genome Project, an international team tracked the gene for hereditary nonpolyposis colon cancer to a region of chromosome 2.

Page 28: Genomics for Obstetrics & Gynecology

ButThe road from gene identification to effective treatments is long and full of challenges

Page 29: Genomics for Obstetrics & Gynecology

So Why?!!!We as Doctors must be aware about the new genetic era and its potential impacts on our specialty so as to offer our patients the most appropriate and informed care.

Page 30: Genomics for Obstetrics & Gynecology

Implantation : the model

Repeated failure of implantation was linked to Leukemia inhibitory Factor gene (LIF)However,

Page 31: Genomics for Obstetrics & Gynecology

ImplantationMicro-array analysis has shown 36 up-regulated genes and 27 down-regulated genes at the implantation site.

Reese J et al, 2001

Page 32: Genomics for Obstetrics & Gynecology

Categorised ingenes with recognized roles in implantation, genes with potential roles in this processgenes whose functions have yet to be defined in this event

Page 33: Genomics for Obstetrics & Gynecology

Polycystic Ovary Syndrome

the insulin gene called variable number tandem repeat (VNTR) gene appears to be a promising candidate

Page 34: Genomics for Obstetrics & Gynecology

Polycystic Ovary Syndrome

follistatin gene as a potential disease locus implicated in ovarian follicular development

Page 35: Genomics for Obstetrics & Gynecology

Polycystic ovary syndrome

CYP11a gene -encoding P450 side chain cleavage-appears to be a major susceptibility locus for steroidogenic abnormalities

Franks et al, 2001

Page 36: Genomics for Obstetrics & Gynecology

MUC 1: a genetic link to infertility?

Women with unexplained infertility were found to have a genetic susceptibility to failure of embryo implantation due to small MUC 1 allele size.

Horne A, et al,2001

Page 37: Genomics for Obstetrics & Gynecology

Inherited breast and ovarian cancer (BRCA 1 and 2; early-onset tumors of breasts and ovaries)

Page 38: Genomics for Obstetrics & Gynecology

Pre-eclampsiaA polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia

Zusterzeel et al 2001

Page 39: Genomics for Obstetrics & Gynecology

Women with the glutathione S-transferase P1b-1b genotype, which could result in lower glutathione S-transferase detoxification capacity, has been linked to higher susceptibility to preeclampsia

Zusterzeel 2000

Page 40: Genomics for Obstetrics & Gynecology

Gynecological oncology

The increased ovarian cancer risk associated with the high-activity of human EPHX gene (epoxide hydrolase)

Page 41: Genomics for Obstetrics & Gynecology

Cystic Fibrosis

three hundred affected children born each year in UK

Although improvements in care and treatment mean that people with cystic fibrosis can now live for up to twenty-five years,

there is no cure

Page 42: Genomics for Obstetrics & Gynecology

Currently Available DNA-Based Gene Tests

Some Alpha-1-antitrypsin deficiencyAlzheimer's diseaseCystic fibrosis

Page 43: Genomics for Obstetrics & Gynecology

Ataxia telangiectasia Gaucher disease Inherited breast and ovarian cancerHereditary nonpolyposis colon cancerCharcot-Marie-Tooth Congenital adrenal hyperplasia

Page 44: Genomics for Obstetrics & Gynecology

Duchenne muscular dystrophy/Becker muscular dystrophy Fanconi anemia Factor V-Leiden Fragile X syndrome Hemophilia A and B Huntington's disease Myotonic dystrophy Neurofibromatosis type 1

Page 45: Genomics for Obstetrics & Gynecology

PhenylketonuriaAdult Polycystic Kidney DiseasePrader Willi/Angelman syndromes Sickle cell disease Spinocerebellar ataxiaSpinal muscular atrophy Thalassemias Tay-Sachs Disease

Page 46: Genomics for Obstetrics & Gynecology

Gene TherapyIt means modification of the genetic material of living cells

This applies to genetically determined diseases but also to diseases that occur later in life

Page 47: Genomics for Obstetrics & Gynecology

Highly promisingTreatmentPreventionImmunity enhancing (e.g., by adding a gene that suppresses tumor growth).

Page 48: Genomics for Obstetrics & Gynecology

Still experimentalmore technological barriers are encountered than foreseen and therefore, the clinical success up to now is limited.

Page 49: Genomics for Obstetrics & Gynecology

HowCells may be modified ex vivo for subsequent administration to patients, or may be altered in vivo by gene therapy given directly to the subject.

Page 50: Genomics for Obstetrics & Gynecology
Page 51: Genomics for Obstetrics & Gynecology

Germ cell gene therapy

Page 52: Genomics for Obstetrics & Gynecology

Two techniquesDeposit corrective genes in the cell’s nucleus, integrate genes into the chromosomes..

Page 53: Genomics for Obstetrics & Gynecology

Somatic cell gene therapy

Page 54: Genomics for Obstetrics & Gynecology

VectorViral genes targeting

the cell's nucleus are retained in the vector, while harmful viral genes are removed and replaced with the corrective gene.

Page 55: Genomics for Obstetrics & Gynecology
Page 56: Genomics for Obstetrics & Gynecology

StepsViruses recognize and attach to receptors (a) and work their way through, into the cell (b). Once inside, the virus discharges its contents (c). Viral genes progress through the cell and into the nucleus (d).

Page 57: Genomics for Obstetrics & Gynecology

Specific TargetEach virus is particularly adapted to use one or a few specific receptors, which limits the range of cells each one can infect.

Page 58: Genomics for Obstetrics & Gynecology

Familial Hypercholesterolemia

A corrective low-density lipoprotein (LDL) receptor gene. A piece of the patient's liver was removed, and the cells were treated with a retrovirus carrying a good copy of the gene. Cells with the corrective gene were reimplanted into the patients's liver.

Page 59: Genomics for Obstetrics & Gynecology

Is it the future!!!gene therapy for single-gene diseases may be routine and successful in 20 years.

Page 60: Genomics for Obstetrics & Gynecology
Page 61: Genomics for Obstetrics & Gynecology

Role in oncology• It has been proven that many cancers are

caused by the mutation of certain genes or lack of gene function

• The introduction of those genes into cancer cells where gene function is compromised, can work to restore gene function and stop tumor progression

Page 62: Genomics for Obstetrics & Gynecology

Cancer Gene Therapy

• The RIZ1 gene is the best example • has potent tumor suppressive activities in

causing apoptosis, G2/M arrest, or both. • Preclinical animal studies have shown that

a recombinant adenovirus expressing the gene, AdRIZ1, can suppress

the growth of colon cancer Canote 2002

Page 63: Genomics for Obstetrics & Gynecology

May be in the futurePatients with cancer may receive combination chemotherapy together with gene therapy for six cycles of treatment and, at that point, the chemotherapy is stopped and patients continue with chronic maintenance biologic therapy

Ozols 2002

Page 64: Genomics for Obstetrics & Gynecology

Gene Therapy: Simple in Theory but Difficult

in Practice

Page 65: Genomics for Obstetrics & Gynecology

Obstacles

SafetyCostsEthics : Baby designers

Page 66: Genomics for Obstetrics & Gynecology

all of the current approaches to gene therapy seek to

introduce the good gene into the so-called somatic cells

of a child or an adult.

Page 67: Genomics for Obstetrics & Gynecology
Page 68: Genomics for Obstetrics & Gynecology